SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Will Not Be Able To Complete Its Review Of Takeda Pharmaceutical Co. Ltd.'s (JOBS) Alogliptin (SYR-322) NDA By The Prescription Drug User Fee Act (PDUFA) Date Of October 27, 2008; Delay Puts PPD, Inc. Payment On Hold